PROCESS FOR PREPARING ZOLMITRIPTAN COMPOUNDS

Details for Australian Patent Application No. 2003250476 (hide)

Owner LABORATORIOS VITA, S. A.

Inventors DALMASES BARJOAN, Pere; ARMENGOL ASPARO, Montserrat

Pub. Number AU-A-2003250476

PCT Number PCT/IB03/03536

PCT Pub. Number WO2004/014901

Priority P200201873 07.08.02 ES

Filing date 5 August 2003

Wipo publication date 25 February 2004

International Classifications

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 491/04 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 413/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

16 October 2003 Complete Application Filed

  Priority application(s): P200201873 07.08.02 ES

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2003250476

21 April 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003250477-Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

2003250475-5,6-FUSED 3,4-DIHYDROPYRIMIDINE-2-ONE DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS